ArticleVaccine2021

Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.

Haitao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.